Nicotinamide adenine dinucleotide (NAD) therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nicotinamide adenine dinucleotide (NAD) therapy, covering 2025-04-04 to 2025-04-04. Get the full timeline:
Most recent: Clinical Trial Update: NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment [Phase 1, Phase 2]